Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg
4 July 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application…